Category Archives: EU

Youngest F1 Drivers For The 2018 Season

The Monaco Grand Prix is the one race of the year that every driver dreams of winning

The Portier corner is key to achieving a good lap time around Monaco. It is preceded by the Loews hairpin, the slowest corner in Formula One, and followed by the tunnel, one of the few flat-out sections of the track. Some great names have ended their races in the barriers here, most notably Ayrton Senna and Michael Schumacher.

To win in Monaco places a driver’s name on a list that includes many of history’s all-time greats. All the top teams have unchanged line-ups for 2018, but there are some exciting moves further down the grid. Therefore, we set the youngest F1 drivers of the season.

Lance Stroll

Lance Stroll

Lance Stroll ( 19 yo)

Born in Montreal, Canada in 1998, Stroll was bitten by the racing bug aged five when his father, eminent businessman and occasional amateur sportscar driver Lawrence Stroll, bought him a go-kart. He won his first race and championship three years later, before being selected for Ferrari’s prestigious Driver Academy in 2010 following more karting success.The 2018 season brings with it a whole new challenge for Stroll – leading Williams’ campaign as Massa is replaced by another rookie in the form of Sergey Sirotkin.

Charles Leclerc

Charles Leclerc

Charles Leclerc (20 yo)

Born on October 16, 1997, Leclerc is barely into his twenties, so it’s fair to say he looks to be firmly on the fast track to success. Hailing from Monaco, he was inevitably exposed to F1 at a young age, especially as his late father Herve was also a racing driver, who shared his passion for Formule One car racing. In 2017, he triumphed seven times to secure the F2 crown in dominant style at his first attempt. There were further F1 tests with the Scuderia, and another four Friday practice outings, this time with the Ferrari-powered Sauber team.With Sauber strengthening their ties to Ferrari with an Alfa Romeo title sponsorship deal for 2018, Leclerc won his first F1 race seat, driving alongside seasoned Swede Marcus Ericsson.

Max Verstappen

Max Verstappen

Max Verstappen (20 yo)

Max Emilian Verstappen was born in Hasselt, in the east of Belgium, on September 30, 1997. Motorsport was in his blood: father Jos was competing in Formula 1 racing at the time – in fact he raced for Tyrrell in Japan 10 days after Max’s arrival – while mother Sophie Kumpen was a successful, and extremely quick, karter. He stunned by winning on debut for his new squad and a further six podiums followed as he impressed all with his daring overtakes and wet-weather prowess. His defensive driving proved somewhat controversial among his peers, but no-one could argue that a new F1 superstar had arrived. And nothing happened to change that in 2017. Red Bull may have dropped off the title-contending pace of Mercedes and Ferrari, but Verstappen proved a close match for team mate Daniel Ricciardo, and despite a woeful lack of luck in terms of engine reliability, secured two race wins to the Australian’s one.


Implementation Of The Portability Regulation

The Portability Regulation comes into force on 1 April 2018. Businesses bound by its obligations must implement by this date

Intellectual Property Office

Intellectual Property Office

Consumers will soon find it easier to access their online film, TV and other subscription services while visiting countries in the EU. For example, you will be able to stream your favourite films and TV programmes and watch sporting events while on holiday or on a short business trip. The EU Portability Regulation, which allows this to happen, applies in the UK from 1 April 2018.

The IPO’s consultation on the enforcement of the EU Portability Regulation closed on 31 January 2018. It asked for comments on proposed enforcement mechanisms and bodies, and topics for guidance. It also asked for views on portability in the context of the UK’s exit from the EU.

There were 12 responses to the consultation. These were from individual online content service providers, their representative bodies and trade associations, and organisations representing copyright owners. No significant issues with the IPO’s proposed approach were identified. The government would like to thank all respondents for their contributions.

The government has now published its response to the consultation.

The government laid the implementing legislation on 28 February 2018. The UK is now fully compliant with the requirements of the EU Portability Regulation. The IPO will produce guidance to assist businesses in understanding their obligations.

U.S. Statement To The 61st Session Of The Commission On Narcotic Drugs

Deputy Secretary of State, Bureau of International Narcotics and Law Enforcement Affairs - Vienna, Austria

James A. Walsh

James A. Walsh

Thank you, Madam Chairman, for the opportunity to deliver remarks at the 61st session of the CND. Thank you also to the Secretariat for its tremendous work in preparing our conference. The United States expresses its appreciation for the partnership, investment, and fellowship within this body to address the complex and ever-evolving challenges presented by the world drug problem.

Now more than ever, our work in the Commission is vital to protecting the health and security of all our citizens. The world drug problem is ever-evolving and changing. Today, we are in the midst of a new drug trafficking paradigm where international criminal organizations trafficking in drugs are evading international controls by creating synthetic drugs – new psychoactive substances (or NPS) – that are mirror images of controlled substances. The UN Office on Drugs and Crime’s Global Synthetics: Monitoring, Analysis, Reporting, and Trends (SMART) program March 2018 update reports that these criminal organizations are producing at least one of these new substances every week, with SMART identifying 70 new substances in 2016 alone.

In this new paradigm, traffickers are also exploiting the online market through open and dark net sites, and then trafficking these substances through the international mail and express consignment shipments. What’s more is that these substances are shipped in small quantities – a couple milligrams for example – making these packages difficult for law enforcement and regulatory officials to identify and intercept.

The dramatic increase in the misuse of synthetic drugs, particularly synthetic opioids – like carfentanil – is plaguing many of our countries. According to UNODC’s 2017 World Drug Report, opioid misuse remains high in Southwest Asia and Eastern Europe, and has been expanding in Western Europe and others parts of North America. An estimated 190,000 deaths globally are attributed to drug use disorders, mostly among people using opioids.

Fighting this plague is also exacting a grisly human toll among many of our law enforcement colleagues. In 2015 and 2016, Colombia lost 290 Ministry of Defense forces and over 3,000 wounded. 2017 was one of the bloodiest years on record in Mexico with over 29,000 murders, including many valiant members of Mexico’s security services battling transnational criminal organizations.

Clearly, this international problem requires a smart, strategic, and coordinated international response, and our decisions here at the CND matter. We must work as an international community to curb this new paradigm in drug trafficking – lives depend upon it. We must work together to identify innovative options to curb the rapid proliferation of these new synthetic drugs. Some of the most dangerous substances in this category are synthetic opioids. Synthetic opioids are fueling thousands of deaths in many of our countries because they are incredibly lethal and difficult to detect.

One of the most dangerous synthetic opioids being trafficked in international criminal markets is carfentanil, which is 10,000 times more potent than morphine. It is an elephant tranquilizer, not approved for use in humans, that has made its way into the illicit drug market, and is being used, sometimes unknowingly. To hinder criminal access to carfentanil and reduce its presence in the illicit drug market, the United States requested that it be controlled under the UN Single Convention on Narcotic Drugs – the 1961 Convention. The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD) reviewed this request and concluded that carfentanil should be controlled under Schedules I and IV and we urge the Commission to vote in favor of this request this week. Broader controls of synthetic drugs is one way we can work together as a community to address this problem.

The United States has also sponsored a resolution this week aimed at enhancing international cooperation to address the threats presented by synthetic drugs, particularly these deadly synthetic opioids. The resolution promotes and amplifies existing tools within UNODC and the INCB to increase information sharing and data collection and analysis that can facilitate real-time cooperation among experts in the field to disrupt the illicit supply of synthetic drugs, and the chemicals used to produce them. The information derived through these efforts can then be used by the WHO to accelerate reviews of substances for international control. Currently, the international community is controlling these substances at a rate of about ten a year. We have to do better. The ideas offered in this resolution – increased information sharing and international cooperation – present options for us to more aggressively attack this threat together. We look forward to discussing the text with you this week, and hope we can mobilize a strategic and coordinated response to this challenge.

Another option to curb this threat is to generate a better understanding of the new drug trafficking pattern whereby synthetic drugs are being sold online and trafficked through express consignment shipments and the mail. To explore this new pattern, the United States sponsored a side event on “New Methods of Synthetic Drug Trafficking” with expert panel presentations on challenges and experiences related to synthetic drugs being sold and trafficked through this method. Through this event, we highlighted the new paradigm, whereby dangerous and deadly synthetic drugs, such as carfentanil, can easily arrive anywhere with an internet connection and international delivery services. With synthetic drugs being so potent, a small amount can be easily shipped and often has higher profit margins than other narcotics.

When you combine these new modalities with a large supply of heroin being trafficked into your country by sophisticated transnational criminal organizations, along with an increase in demand fueled by an excess of prescriptions pills, you have a crisis; a crisis where thousands of my fellow Americans are dying annually. In 2016, nearly 64,000 people died from drug overdoses in the United States. Of these 64,000, over two-thirds, died from overdoses involving prescription or illicit opioids, including fentanyl. And we are not alone here.

This new trafficking pattern shows that we are all vulnerable. Anyone with an internet connection and access to international mail can be next. So the world must be vigilant and respond to this new threat. Whether it is fentanyl or tramadol, or another a new synthetic concocted by a rogue chemist, it is imperative that we work together to get ahead of this problem; we must be proactive, not reactive.

In thinking proactively, we should prioritize life-saving efforts to address this international crisis beyond the 2019 High-Level Ministerial Segment of the 62nd CND. The “beyond 2019” drug-policy trajectory must focus on this “new reality.” In the 2016 outcome document from the UN General Assembly Special Session on the World Drug Problem (UNGASS), we highlighted the rapid proliferation of synthetic drugs, or NPS, as one of these new realities to be prioritized. The outcome document represents the latest international consensus that reaffirms the Commission’s primary role in international drug policy. On the road to 2019 and beyond, we want the Commission implementing the operational recommendations in the outcome document to promote a society free of drug abuse, with an acute focus on working together to address the new realities of “today’s” world drug problem.

Again, I am very excited to be here to work through these issues. Thank you.

PM Meeting With Prime Minister Muscat Of Malta

On Commonwealth Day, Prime Minister Theresa May held a meeting with Maltese Prime Minister Joseph Muscat

10 Downing Street

10 Downing Street

A Downing Street spokesperson said:

This afternoon the Prime Minister held a bilateral meeting with Prime Minister Muscat of Malta ahead of the Commonwealth Day Service at Westminster Abbey. The Prime Minister thanked Prime Minister Muscat for the progress made on the reform agenda during Malta’s Chair-in-Office of the Commonwealth. Both leaders looked forward to the upcoming Commonwealth Heads of Government Meeting in April.

The leaders also discussed the ongoing Brexit negotiations, with Prime Minister Muscat welcoming the further detail provided in the Prime Minister’s recent Mansion House speech. The Prime Minister reiterated that the UK is ambitious about the future relationship with the EU including on services. She also noted the importance of the UK and the EU reaching agreement on the terms of the implementation period at the March European Council.

Llanelli Vinyl Vendor Jailed For Selling Illegal Cancer Drugs Across The EU

Lee Daniels received a 40-month sentence for selling unauthorised versions of anti-cancer drugs such as Tamoxifen and Letrozole across the EU



A Llanelli man has been sentenced today for illegally supplying prescription drugs. Lee Daniels received a 40-month sentence for selling unauthorised versions of anti-cancer drugs such as Tamoxifen and Letrozole as well as steroids and pain killers across the EU.

More than 25,000 doses of unlicensed, prescription-only medicines and class C drugs were seized by Medicines and Healthcare Products Regulatory Agency investigators including addictive benzodiazepines. Daniels conducted his illegal trade in medicines whilst also running a business selling vinyl records.

Investigators believe that Daniels made more than £270K from his illegal medicines business between 2013 and 2016. The profits were deposited into accounts held under variations of his own name and in to accounts in the name of his wife and a friend who it is believed were completely unaware of his illegal business.

Daniels worked full-time as a welder before branching out in to selling discs and diazepam. He was eventually uncovered when a raid at an associate’s warehouse resulted in hand-written notes being seized which led investigators to his address.

Daniels sold powerful medicines with potentially dangerous side effects directly to the public. He often sold cheap, untested, unlicensed versions of these medicines and did so without any form of medical supervision or prescribing. His customers were put at serious risk by his activities.

Alastair Jeffrey, MHRA Head of Enforcement said:

Selling medicines outside of the regulated supply chain is a serious criminal offence. These criminals are motivated by greed and have no concern about your safety or welfare.

Always seek professional help and visit your GP if you are ill. If you buy medicines online, you are trusting a criminal to look after your health.

MHRA is currently running the #FakeMeds campaign to warn people against buying potentially dangerous or useless unlicensed medicines sold by illegal online suppliers. Visit for tips on buying medicines safely online and how to avoid unscrupulous sites.

« Older Entries